Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

fresenius medical care nephrologica deutschland gmbh - paricalcitol - solution for injection - 2 microgram/ml

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

fresenius medical care nephrologica deutschland gmbh - paricalcitol - solution for injection - 5 microgram/ml

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 16.5 g/l; lactic acid as sodium 3.925 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - lactic acid as sodium 3.925 g/l; calcium chloride 0.2573 g/l; glucose as monohydrate 46.75 g/l; magnesium chloride 0.1017 g/l; sodium chloride 5.786 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

Ισραήλ - Αγγλικά - Ministry of Health

fresenius medical care israel p.b. ltd - calcium chloride; glucose as monohydrate; lactic acid as sodium; magnesium chloride; sodium chloride - solution for peritoneal dialysis - calcium chloride 0.2573 g/l; sodium chloride 5.786 g/l; glucose as monohydrate 25 g/l; lactic acid as sodium 3.925 g/l; magnesium chloride 0.1017 g/l - combinations of electrolytes - combinations of electrolytes - for use in patients with end-stage (decompensated) chronic renal failure of any origin being maintained on peritoneal dialysis.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - it is intended for the purification of dialysate.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - it is intended for the preparation of ultra pure fluid for use in dialysis.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - it is intended for single use only for extracorporeal blood purifications.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - it is designed for single use in acute dialysis with machine-assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration.

Σιγκαπούρη - Αγγλικά - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - (solution a) anhydrous glucose 20 g/l eqv glucose monohydrate; (solution a) calcium chloride dihydrate; (solution a) magnesium chloride hexahydrate; (solution b) sodium chloride; (solution b) sodium hydrogen carbonate - solution, sterile - 0.2205 g/1000 ml - (solution a) anhydrous glucose 20 g/l eqv glucose monohydrate 22.00g/l; (solution a) calcium chloride dihydrate 4.410g/l; (solution a) magnesium chloride hexahydrate 2.033g/l; (solution b) sodium chloride 6.453g/l; (solution b) sodium hydrogen carbonate 3.104g/l